The expansion of the Clinical Trials Market is fundamentally linked to the growing pipeline of biologic and cell therapy products. Unlike traditional small-molecule drugs, these advanced therapies require highly specialized manufacturing and clinical trial environments, forcing the industry to adapt its standard operating procedures. This necessity has spurred significant infrastructure...